Email this article Clinicopathogenetic variants of chronic gastritis
- Authors: Chernin VV1, Dzhulai GS1
-
Affiliations:
- Issue: Vol 79, No 2 (2004)
- Pages: 22-27
- Section: Editorial
- Submitted: 09.04.2020
- Published: 15.02.2004
- URL: https://ter-arkhiv.ru/0040-3660/article/view/29746
- ID: 29746
Cite item
Full Text
Abstract
Aim. To evaluate specific features of the course of chronic gastritis (CG), morphofunctional condition of gastric mucosa, vegetative regulation, adrenergic and cholinergic shifts, histamine metabolism and effects of exogenic and endogenic risk factors in CG patients; to study clinicopathogenetic variants of CG.
Material and methods. A total of 311 CG patients aged from 16 to 72 years were studied. They were divided into three groups by their gastric mucosa condition. The control group consisted of 30 healthy donors. The following parameters were studied: visual and histological condition of gastric mucosa, total acidity, the levels of free hydrochloric acid, pepsin, bioelectric gastric activity, general autonomic tonicity, cholinesterase activity.
Results. Three clinicopathogenetic variants of the disease have been identified. Variant 1 was characterized by a recurrent course, subjective manifestation of the disease only in exacerbation, surface (primarily antral) mucosal affection, normal or enhanced secretory and motor functions of the stomach, adequate reaction of acid production to caffeine and histamine stimulation, parasympathicotonia, absolute hyperhistaminemia, relative hypoacetylcholinemia, subnormal urinary excretion of adrenalin. Variant 2 manifested with rare recurrences, longer and more severe exacerbations, frequent spontaneous and provoked aggravations, moderate focal atrophy of the mucosa, secretory insufficiency with adequate reaction to histamine and minor to caffeine stimuli, hypomotor gastric dyskinesia, vegetative eutonia, normohistaminemia, absolute hypoacetylcholinemia, subnormal urinary excretion of noradrenaline. Variant 3 runs without definite remissions and exacerbations, with continuous abdominal pain and dyspepsia, frequent spontaneous aggravations, marked extended mucosal atrophy with secretory insufficiency up to achlorhydria, no stimulation of acid production in response to caffeine and histamine, gastric hypomotility, sympathicotonia, absolute hypohistaminemia, hypoacetylcholinemia, normal urinary excretion of catecholamines.
Conclusion. The findings expand our knowledge about clinicopathogenetic variants of CG and necessitate new approaches to development of effective methods of CG prevention and treatment.
Material and methods. A total of 311 CG patients aged from 16 to 72 years were studied. They were divided into three groups by their gastric mucosa condition. The control group consisted of 30 healthy donors. The following parameters were studied: visual and histological condition of gastric mucosa, total acidity, the levels of free hydrochloric acid, pepsin, bioelectric gastric activity, general autonomic tonicity, cholinesterase activity.
Results. Three clinicopathogenetic variants of the disease have been identified. Variant 1 was characterized by a recurrent course, subjective manifestation of the disease only in exacerbation, surface (primarily antral) mucosal affection, normal or enhanced secretory and motor functions of the stomach, adequate reaction of acid production to caffeine and histamine stimulation, parasympathicotonia, absolute hyperhistaminemia, relative hypoacetylcholinemia, subnormal urinary excretion of adrenalin. Variant 2 manifested with rare recurrences, longer and more severe exacerbations, frequent spontaneous and provoked aggravations, moderate focal atrophy of the mucosa, secretory insufficiency with adequate reaction to histamine and minor to caffeine stimuli, hypomotor gastric dyskinesia, vegetative eutonia, normohistaminemia, absolute hypoacetylcholinemia, subnormal urinary excretion of noradrenaline. Variant 3 runs without definite remissions and exacerbations, with continuous abdominal pain and dyspepsia, frequent spontaneous aggravations, marked extended mucosal atrophy with secretory insufficiency up to achlorhydria, no stimulation of acid production in response to caffeine and histamine, gastric hypomotility, sympathicotonia, absolute hypohistaminemia, hypoacetylcholinemia, normal urinary excretion of catecholamines.
Conclusion. The findings expand our knowledge about clinicopathogenetic variants of CG and necessitate new approaches to development of effective methods of CG prevention and treatment.
References
- Фишзон-Рысс Ю. И. Гастриты. Л.: Медицина; 1974.
- Дорофеев Г. И., Успенский В. М. Гастродуоденальные заболевания в молодом возрасте. М: Медицина; 1984.
- Гребнев А. Л., Шептулин А. А. Хронический гастрит. В кн.: Комаров Ф. И., Гребнев А. Л. (ред.) Руководство по гастроэнтерологии. М.: Медицина; 1995; т. 1: 400-433.
- Масевич Ц. Г. Гастриты. В кн.: Рысс. Е. С. (ред.) Заболевания органов пищеварения. СПб; 1995; ч. 1: 153-217.
- Комаров Ф. И., Заводская И. С., Морева Е. В., Щедрунов В. В. Нейрогенные механизмы гастродуоденальной патологии (экспериментальные и клинические данные). М.: Медицина; 1984.
- Логинов А. С., Царегородцева Т. М., Зотина М. М. Иммунная система и болезни органов пищеварения. М.: Медицина; 1986.
- Циммерман Я. С. Хронический гастрит и язвенная болезнь (очерки клинической гастроэнтерологии). Пермь: ПГМА; 2000.
- Аруин Л. И., Григорьев П. Я., Исаков В. А., Яковенко Э. П. Хронический гастрит. Амстердам; 1993.
- Григорьев П. Я., Яковенко Э. П. Диагностика и лечение болезней органов пищеварения. М.: Медицина; 1996.
- Ивашкин В. Т., Лапина Т. Л. Хронический гастрит: современные представления, принципы диагностики и лечения. Рус. мед. журн. 2001; 2: 54-60.
- Туголуков В. Н. Определение пепсина в желудочном соке и пепсиногена в моче единым методом. Лаб. дело. 1962; 3: 3-8.
- Hestrin S. The reaction of acetylcholine and other carboxylic acid derivates with hydroxylamine and its analytical application. J. Biol. Chem. 1949; 180: 249-262.
- Glass G. В., Boyd L. D. Studies on the non-parietal component of gastric secretion in humans. Part II. Gastroenterology 1952; 20 (3): 430-442.
- Собакин М. А. Клинико-физиологическая методика исследования моторной деятельности желудка при пищеварении: Сообщение 2. Бюл. экспер. биол. 1953; 2: 63-66.
- Вейн А. М. (ред.) Вегетативные расстройства. Клиника, лечение, диагностика. М.: МИА; 2000.
- Ворончихина Л. Д. К методике спектрофотометрического определения гистамина в крови. Лаб. дело 1974; 11; 672- 673.
- Пушкина Н. Н. Биохимические методы исследования. М.; 1963.
- Меньшиков В. В. Об определении катехоламинов в моче. Лаб. дело 1961; 4: 18-21.
- Эйдельман Ф. М. Методика определения гистаминопексического индекса и активности гистаминазы крови. Врач. дело 1967; 11: 140-141.
Supplementary files
